Immunotherapy: Myths & Pearls

In this episode of Lung Cancer Considered, host Dr. Stephen Liu is joined by Dr. Jarushka Naidoo for an in-depth discussion of immunotherapy in lung cancer, specifically addressing common myths and clinical pearls on immune-related toxicities. The conversation explores how to communicate risk and side effects with patients, the timing and chronicity of immune-related adverse events, and misconceptions about the link between toxicity and favorable outcomes. Dr. Naidoo also discusses approaches to rechallenging therapy, the role of steroids, and resources for clinicians managing complex immune toxicities, offering balanced insights for both oncology professionals and patients.